文献速递鼻科

COVID-19 疫情期间牙源性鼻窦炎发病率的变化趋势

Trends of Odontogenic Sinusitis Incidence During the COVID-19 Pandemic.
PubMed 文献 · Laryngoscope · 2023-09-29

本研究回顾性分析某三级转诊中心接受上颌窦开窗术的患者,比较疫情前(2018年3月至2020年2月)与疫情期间(2020年3月至2022年2月)牙源性鼻窦炎(ODS)的发病率。结果显示,疫情期间ODS发病率较疫情前升高(12.2% vs 6%,p=0.006),两组临床特征相似。

要点

  • 疫情期间接受上颌窦开窗术者中ODS占12.2%,疫情前为6%(p=0.006)。
  • 疫情前组蝶窦受累比例高于疫情期间组(31.8% vs 8.9%,p<0.05)。
  • 两组糖尿病、肥胖及免疫抑制发生率无显著差异。

核心结论

  • COVID-19 大流行头两年牙源性鼻窦炎发病率较之前两年升高,两组临床特征相似。

研究设计与样本

  • 回顾性病历审查,纳入某三级转诊中心接受至少上颌窦开窗术的患者共734例,分为疫情前组(2018年3月至2020年2月)和疫情期间组(2020年3月至2022年2月)。

主要发现

  • 734例接受上颌窦开窗术的患者中,370例(50.4%)在疫情期间手术,平均年龄53.1±15.7岁。
  • 牙源性鼻窦炎在疫情前组占22例(6%),疫情期间组占45例(12.2%),差异有统计学意义(p=0.006)。
  • 两组糖尿病发生率无差异(p=0.9),肥胖发生率无差异(p=0.7)。
  • 疫情前组免疫抑制发生率呈较高趋势(18.2% vs 0%,p=0.06)。
  • 疫情前组蝶窦受累发生率较高(31.8% vs 8.9%,p<0.05);筛窦受累(86.4% vs 86.7%,p=0.999)和额窦受累(54.5% vs 37.8%,p=0.3)两组无差异。

临床怎么用

  • 作者认为,未来针对特定病因的研究可能有助于确定牙源性鼻窦炎的最佳治疗和预防策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The COVID-19 pandemic affected the epidemiology of several diseases. This study aims to compare the incidence of surgically treated odontogenic sinusitis (ODS) before and during the COVID-19 pandemic and identify unique features. METHODS: A retrospective chart review of patients who underwent at least maxillary antrostomy at a tertiary referral center was performed. The patients were divided into two cohorts: "pre-COVID" (March 2018 to February 2020) and "COVID" (March 2020 to February 2022). Data on demographics, comorbidities, and treatment interventions were collected and analyzed. RESULTS: Of the 734 patients who underwent maxillary antrostomy, 370 (50.4%) were operated on during the COVID period, with a mean age of 53.1 ± 15.7 years. ODS was found as the etiology of 22 (6%) and 45 (12.2%) of the pre-COVID and COVID cases, respectively (p = 0.006). Although no difference was found in the incidence of diabetes (p = 0.9) or obesity (p = 0.7) between groups, a trend toward higher incidence of immunosuppression was found in the pre-COVID patients (18.2% vs. 0%, p = 0.06). A higher incidence of sphenoid sinus involvement (31.8% vs. 8.9%, p < 0.05) was identified in the pre-COVID group; however, no differences in ethmoid (86.4% vs. 86.7%, p = 0.999) or frontal sinus involvement (54.5% vs. 37.8%, p = 0.3) were found between the groups. CONCLUSION: There was an increase in the incidence of ODS during the first 2 years of the COVID-19 pandemic compared to the 2 years prior. Similar clinical characteristics were found in both groups. Future studies focusing on specific etiologies to explain ODS preponderance may help determine optimal treatment and prevention strategies. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:1597-1602, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Ringel B, Kons ZA, Holbrook EH, et al. Trends of Odontogenic Sinusitis Incidence During the COVID-19 Pandemic. Laryngoscope. 2023. PMID: 37772908. doi:10.1002/lary.31082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。